Research ArticleArticle
Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Inhibition and Biomarker Modulation by the Novel Phosphatidylinositol 3-Kinase Inhibitor GDC-0941
Laurent Salphati, Harvey Wong, Marcia Belvin, Delia Bradford, Kyle A. Edgar, Wei Wei Prior, Deepak Sampath and Jeffrey J. Wallin
Drug Metabolism and Disposition September 2010, 38 (9) 1436-1442; DOI: https://doi.org/10.1124/dmd.110.032912
Laurent Salphati
Harvey Wong
Marcia Belvin
Delia Bradford
Kyle A. Edgar
Wei Wei Prior
Deepak Sampath
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Inhibition and Biomarker Modulation by the Novel Phosphatidylinositol 3-Kinase Inhibitor GDC-0941
Laurent Salphati, Harvey Wong, Marcia Belvin, Delia Bradford, Kyle A. Edgar, Wei Wei Prior, Deepak Sampath and Jeffrey J. Wallin
Drug Metabolism and Disposition September 1, 2010, 38 (9) 1436-1442; DOI: https://doi.org/10.1124/dmd.110.032912
Research ArticleArticle
Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Inhibition and Biomarker Modulation by the Novel Phosphatidylinositol 3-Kinase Inhibitor GDC-0941
Laurent Salphati, Harvey Wong, Marcia Belvin, Delia Bradford, Kyle A. Edgar, Wei Wei Prior, Deepak Sampath and Jeffrey J. Wallin
Drug Metabolism and Disposition September 1, 2010, 38 (9) 1436-1442; DOI: https://doi.org/10.1124/dmd.110.032912
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement